The Economic Times reported Sun Pharmaceutical Industries Limited (Sun Pharma) shares above a reported 20-day simple moving average in early trading Oct. 30, the date set for a board meeting to consider and approve results.
In its 11:46:26 p.m. ET update on Oct. 29, the outlet put the shares at ₹1,772.50, up 0.65%, and the reported average at ₹1,765.30. The Economic Times also reported a 5.58% decline over the previous month; Kotak Neo listed the same one-month return.
Market-data pages from The Economic Times and Business Standard listed Sun Pharma’s Oct. 29 closing price at ₹1,761, up 0.20% from ₹1,757.50 on Oct. 28. EconoTimes earlier covered Sun Pharma’s Oct. 21 recovery from an intraday dip ahead of the same results date.
In an Oct. 14 filing, Sun Pharma said its board was scheduled to meet Oct. 30 to consider and approve unaudited standalone and consolidated results covering the quarter and six-month period through Sept. 30, 2026.
